Back to search

Peptide record

TPDB91930

LA-C1b Antibacterial Anticancer Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB91930
LA-C1b
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 dbACP
standard
No
A 18-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation Chemical: Lauric acid conjugated to the 17th Lys-residue
Sequence
SKVWRHWRRFWHRAHRLH-NH2
Physicochemical Analysis
C119H171N45O20
NDCEQGIMPTY
R
2551.96
13.00
10
0
7
+6
1.67
-1.672
43.33
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
16500
646.56
1
Residue Composition
number
1
A
5
R
0
N
0
D
0
C
0
E
0
Q
0
G
4
H
0
I
1
L
1
K
0
M
1
F
0
P
1
S
0
T
3
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 5 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 4 I: 0 L: 1 K: 1 M: 0 F: 1 P: 0 S: 1 T: 0 W: 3 Y: 0 V: 1
Chemical Descriptors
18
C119H171N45O20
2551.96
13.00
+6
1.67
-1.672
Amidation
Lauric acid conjugated to the 17th Lys-residue
L
Linear
Free
Anticancer
Synthetic
Evidence Records 3 records
Evidence 1 Activity

Activity

Not Available
Anticancer

Target

Breast Cancer
MCF-7
Breast

Assay & Model

Not Available
Not Available

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2022

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

Not Available
Anticancer

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

Not Available
Not Available

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2022
Evidence 3 Activity

Activity

Not Available
Anticancer

Target

Skin Cancer
A-375
Skin

Assay & Model

Not Available
Not Available

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2022